Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical treatments to prevent squamous cell carcinoma in organ transplant recipients
ISRCTN26398197Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Dec 2014
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of fluorouracil and imiquimod in actinic keratosis (AK) and cutaneous squamous cell carcinoma (cSCC) (3 arms), sponsored by Queen Mary University of London. Primary endpoint: Willingness to use treatment again. Started Dec 2014; status: completed.
02
Drugs
fluorouracilimiquimod
03
Conditions
actinic keratosis (AK)cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on ISRCTN26398197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26398197.